Surmodics reported $17.66M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Align Technology ALGN:US $ 1696.58M 302.74M
Anika Therapeutics ANIK:US $ 41.37M 5.61M
Arrowhead Research ARWR:US $ 195.43M 28.25M
Baxter International BAX:US $ 3344M 157M
Bioscrip BIOS:US $ 459.52M 39.35M
Cryolife CRY:US $ 58.94M 0.93M
Edap Tms EDAP:US $ 15.35M 3.92M
Edwards Lifesciences EW:US $ 886.2M 87.2M
Genmark Diagnostics GNMK:US $ 44.13M 3.46M
Haemonetics HAE:US $ 228.34M 25.16M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Merit Medical Systems MMSI:US $ 210.6M 2.93M
Mesa Laboratories MLAB:US $ 33.45M 0.86M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Oxford Immunotec Global OXFD:US $ 11.8M 0.99M
Providence Service PRSC:US $ 529.25M 43.16M
Stryker SYK:US $ 4252M 299M
Surmodics SRDX:US $ 17.66M 1.96M